Literature for peptidase S01.306: kallikrein-related peptidase 13
(Topics flags: A Assay, M Mutation, R Splicing, P Specificity, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)
-
Kim,H., Kang,Y., Kim,S., Park,D., Heo,S.Y., Yoo,J.S., Choi,I., N,M.P.A., Ahn,J.W., Yang,J.S., Bak,N., Kim,K.K., Lee,J.Y. and Choi,Y.K.
The host protease KLK5 primes and activates spike proteins to promote human betacoronavirus replication and lung inflammation
Sci Signal17, eadn3785-eadn3785. PubMed Europe PubMed DOI -
Sumiya,R., Yamada,K., Hagiwara,T., Nagasaka,S., Miyazaki,H., Igari,T. and Kawamura,Y.I.
Kallikrein-related peptidase 13 expression and clinicopathological features in lung squamous cell carcinoma
Mol Clin Oncol19, 64-64. PubMed Europe PubMed DOI -
Milewska,A., Falkowski,K., Kulczycka,M., Bielecka,E., Naskalska,A., Mak,P., Lesner,A., Ochman,M., Urlik,M., Diamandis,E., Prassas,I., Potempa,J., Kantyka,T. and Pyrc,K.
Kallikrein 13 serves as a priming protease during infection by the human coronavirus HKU1
Sci Signal13, PubMed Europe PubMed DOI -
Gruba,N., Bielecka,E., Wysocka,M., Wojtysiak,A., Brzezinska-Bodal,M., Sychowska,K., Kalinska,M., Magoch,M., Pecak,A., Falkowski,K., Wisniewska,M., Sasiadek,L., Plaza,K., Kroll,E., Pejkovska,A., Rehders,M., Brix,K., Dubin,G., Kantyka,T., Potempa,J. and Lesner,A.
Development of chemical tools to monitor human kallikrein 13 (KLK13) activity
Int J Mol Sci20, PubMed Europe PubMed DOI A -
Karakosta,T.D., Soosaipillai,A., Diamandis,E.P., Batruch,I. and Drabovich,A.P.
Quantification of human kallikrein-related peptidases in biological fluids by multiplatform targeted mass spectrometry assays
Mol Cell Proteomics15, 2863-2876. PubMed Europe PubMed DOI A -
Plaza,K., Kalinska,M., Bochenska,O., Meyer-Hoffert,U., Wu,Z., Fischer,J., Falkowski,K., Sasiadek,L., Bielecka,E., Potempa,B., Kozik,A., Potempa,J. and Kantyka,T.
Gingipains of Porphyromonas gingivalis affect the stability and function of serine protease inhibitor of Kazal-type 6 (SPINK6), a tissue inhibitor of human kallikreins
J Biol Chem291, 18753-18764. PubMed Europe PubMed DOI -
Angelopoulou,K. and Karagiannis,G.S.
Identification, molecular characterization and alternative splicing of three novel members of the canine kallikrein (Klk)-related peptidase family
Anticancer Res35, 2715-2723. PubMed Europe PubMed -
Ishige,S., Kasamatsu,A., Ogoshi,K., Saito,Y., Usukura,K., Yokoe,H., Kouzu,Y., Koike,H., Sakamoto,Y., Ogawara,K., Shiiba,M., Tanzawa,H. and Uzawa,K.
Decreased expression of kallikrein-related peptidase 13: Possible contribution to metastasis of human oral cancer
Mol Carcinog53, 557-565. PubMed Europe PubMed DOI -
Lose,F., Batra,J., O'Mara,T., Fahey,P., Marquart,L., Eeles,R.A., Easton,D.F., Al Olama,A.A., Kote-Jarai,Z., Guy,M., Muir,K., Lophatananon,A., Rahman,A.A., Neal,D.E., Hamdy,F.C., Donovan,J.L., Chambers,S., Gardiner,R.A., Aitken,J.F., Yaxley,J., Alexander,K., Clements,J.A., Spurdle,A.B. and Kedda,M.A.
Common variation in kallikrein genes KLK5, KLK6, KLK12, and KLK13 and risk of prostate cancer and tumor aggressiveness
Urol Oncol31, 635-643. PubMed Europe PubMed DOI M -
Lundwall,A.
Old genes and new genes: The evolution of the kallikrein locus
Thromb Haemost110, 469-475. PubMed Europe PubMed DOI V -
Clements,J.A., Hooper,J.D. and Dong,Y.
The human tissue kallikrein and kallikrein-related peptidase family
[ISSN:978-0-12-407742-3]3, 2747-2756. DOI -
Cretu,D. and Diamandis,E.P.
Kallikrein-related peptidase 13
[ISSN:978-0-12-407742-3]3, 2805-2808. DOI -
Andrade,D., Assis,D.M., Santos,J.A., Alves,F.M., Hirata,I.Y., Araujo,M.S., Blaber,S.I., Blaber,M., Juliano,M.A. and Juliano,L.
Substrate specificity of kallikrein-related peptidase 13 activated by salts or glycosaminoglycans and a search for natural substrate candidates
Biochimie93, 1701-1709. PubMed Europe PubMed DOI P -
Clements,J.A.
Reflections on the tissue kallikrein and kallikrein-related peptidase family - from mice to men - what have we learnt in the last two decades?
Biol Chem389, 1447-1454. PubMed Europe PubMed DOI V -
Planque,C., Blechet,C., Ayadi-Kaddour,A., Heuze-Vourc'h,N., Dumont,P., Guyetant,S., Diamandis,E.P., El Mezni,F. and Courty,Y.
Quantitative RT-PCR analysis and immunohistochemical localization of the kallikrein-related peptidases 13 and 14 in lung
Biol Chem389, 781-786. PubMed Europe PubMed DOI -
Borgono,C.A., Gavigan,J.A., Alves,J., Bowles,B., Harris,J.L., Sotiropoulou,G. and Diamandis,E.P.
Defining the extended substrate specificity of kallikrein 1-related peptidases
Biol Chem388, 1215-1225. PubMed Europe PubMed DOI P -
Fernando,S.C., Najar,F.Z., Guo,X., Zhou,L., Fu,Y., Geisert,R.D., Roe,B.A. and DeSilva,U.
Porcine kallikrein gene family: genomic structure, mapping, and differential expression analysis
Genomics89, 429-438. PubMed Europe PubMed DOI -
Yoon,H., Laxmikanthan,G., Lee,J., Blaber,S.I., Rodriguez,A., Kogot,J.M., Scarisbrick,I.A. and Blaber,M.
Activation profiles and regulatory cascades of the human kallikrein-related peptidases
J Biol Chem282, 31852-31864. PubMed Europe PubMed DOI V -
Luo,L.Y. and Jiang,W.
Inhibition profiles of human tissue kallikreins by serine protease inhibitors
Biol Chem387, 813-816. PubMed Europe PubMed DOI -
[YEAR:25-5-2005]Kurlender,L., Borgono,C., Michael,I.P., Obiezu,C., Elliott,M.B., Yousef,G.M. and Diamandis,E.P.
A survey of alternative transcripts of human tissue kallikrein genes
Biochim Biophys Acta1755, 1-14. PubMed Europe PubMed DOI R -
Clements,J.A., Hooper,J.D., Odorico,D.M. and Dong,Y.
The tissue kallikrein gene cluster
[ISSN:0-12-079610-4]2, 1569-1577. V -
Kapadia,C., Yousef,G.M., Mellati,A.A., Magklara,A., Wasney,G.A. and Diamandis,E.P.
Complex formation between human kallikrein 13 and serum protease inhibitors
Clin Chim Acta339, 157-167. PubMed Europe PubMed DOI -
[YEAR:22-10-2004]Kapadia,C., Ghosh,M.C., Grass,L. and Diamandis,E.P.
Human kallikrein 13 involvement in extracellular matrix degradation
Biochem Biophys Res Commun323, 1084-1090. PubMed Europe PubMed DOI -
[YEAR:15-2-2004]Scorilas,A., Borgono,C.A., Harbeck,N., Dorn,J., Schmalfeldt,B., Schmitt,M. and Diamandis,E.P.
Human kallikrein 13 protein in ovarian cancer cytosols: a new favorable prognostic marker
J Clin Oncol22, 678-685. PubMed Europe PubMed DOI -
Kapadia,C., Chang,A., Sotiropoulou,G., Yousef,G.M., Grass,L., Soosaipillai,A., Xing,X., Howarth,D.H. and Diamandis,E.P.
Human kallikrein 13: production and purification of recombinant protein and monoclonal and polyclonal antibodies, and development of a sensitive and specific immunofluorometric assay
Clin Chem49, 77-86. PubMed Europe PubMed DOI A -
Petraki,C.D., Karavana,V.N. and Diamandis,E.P.
Human kallikrein 13 expression in normal tissues: an immunohistochemical study
J Histochem Cytochem51, 493-501. PubMed Europe PubMed -
[YEAR:6-5-2002]Chang,A., Yousef,G.M., Scorilas,A., Grass,L., Sismondi,P., Ponzone,R. and Diamandis,E.P.
Human kallikrein gene 13 (KLK13) expression by quantitative RT-PCR: an independent indicator of favourable prognosis in breast cancer
Br J Cancer86, 1457-1464. PubMed Europe PubMed DOI -
Chang,A., Yousef,G.M., Jung,K., Rajpert-De Meyts,E. and Diamandis,E.P.
Identification and molecular characterization of five novel kallikrein gene 13 (KLK13; KLK-L4) splice variants: Differential expression in the human testis and testicular cancer
Anticancer Res21, 3147-3152. PubMed Europe PubMed -
Clements,J., Hooper,J., Dong,Y. and Harvey,T.
The expanded human kallikrein (KLK) gene family: genomic organisation, tissue-specific expression and potential functions
Biol Chem382, 5-14. PubMed Europe PubMed DOI V -
Diamandis,E.P., Yousef,G.M., Luo,L.Y., Magklara,A. and Obiezu,C.V.
The new human kallikrein gene family: implications in carcinogenesis
Trends Endocrinol Metab11, 54-60. PubMed Europe PubMed DOI -
[YEAR:21-4-2000]Yousef,G.M., Chang,A. and Diamandis,E.P.
Identification and characterization of KLK-L4, a new kallikrein-like gene that appears to be down-regulated in breast cancer tissues
J Biol Chem275, 11891-11898. PubMed Europe PubMed DOI
2024
2023
2020
2019
2016
2015
2014
2013
2012
2011
2008
2007
2006
2005
2004
2003
2002
2001
2000
